✦ LIBER ✦

Pioglitazone reduces monocyte activation in type 2 diabetes

✍ Scribed by Dario Pitocco; Simona Giubilato; Francesco Zaccardi; Enrico Di Stasio; Antonino Buffon; Luigi M. Biasucci; Giovanna Liuzzo; Filippo Crea; Giovanni Ghirlanda

Book ID: 106194279
Publisher: Springer
Year: 2008
Tongue: English
Weight: 135 KB
Volume: 46
Category: Article
ISSN: 0940-5429
DOI: 10.1007/s00592-008-0058-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pioglitazone reduces urinary podocyte ex

Pioglitazone reduces urinary podocyte excretion in type 2 diabetes patients with microalbuminuria

✍ Tsukasa Nakamura; Chifuyu Ushiyama; Shiwori Osada; Masanori Hara; Noriaki Shimad 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 205 KB

261: Pioglitazone Reduces Renal Fibrosis

261: Pioglitazone Reduces Renal Fibrosis in a Rat Model of Type 2 Diabetes

📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 564 KB

Hydrochloride pioglitazone decreases uri

Hydrochloride pioglitazone decreases urinary monocyte chemoattractant protein-1 excretion in type 2 diabetics

✍ Shandong Ye; Mao Zheng; Yuanyuan Hu; FengzhenWu; Lili Zhao; Yan Chen 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 255 KB

Pioglitazone and sulfonylureas: effectiv

Pioglitazone and sulfonylureas: effectively treating type 2 diabetes

✍ M. Hanefeld 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB

Pioglitazone, but not metformin, reduces

Pioglitazone, but not metformin, reduces liver fat in Type-2 diabetes mellitus independent of weight changes

✍ Alok K. Gupta; George A. Bray; Frank L. Greenway; Corby K. Martin; William D. Jo 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 294 KB

Proinflammatory and atherogenic activity

Proinflammatory and atherogenic activity of monocytes in Type 2 diabetes

✍ Małgorzata Gacka; Tadeusz Dobosz; Stanisław Szymaniec; Dorota Bednarska-Chabowsk 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 267 KB